THC

Last Updated: April 11, 2024

Delta-9-tetrahydrocannabinol (THC) is the main psychoactive compound found in cannabis, and it is used both recreationally and medicinally. Evidence suggests that THC may reduce neuropathic pain and nausea and vomiting due to chemotherapy. However, THC comes with a laundry list of downsides that must be considered.

dosageDosage
research-feedResearch feed

THC is most often used for

What is THC?

Tetrahydrocannabinol (THC) is one of the major active cannabinoids found in cannabis. It is the main compound responsible for the psychoactive effects of cannabis, including changes in mental processes (e.g., thoughts, mood, and perception) that cause the feeling of being “high”.[3] While THC is found naturally in cannabis in combination with many other active compounds, like cannabidiol (CBD), some supplements and prescription medications contain isolated THC or synthetic THC analogs, which will be the focus of this page.

What are THC’s main benefits?

THC may have some therapeutic benefits on pain and chemotherapy-induced nausea and vomiting. Despite these potential benefits, THC can induce intoxication and cause other side effects that may reduce the quality of life for some people.[4][5] On the flip side, some people seek out THC recreationally for its intoxicating effects, which can include euphoria, a sense of relaxation, and altered sensory perception.

THC is likely effective for reducing nausea and vomiting in children and adults undergoing chemotherapy. The effects are superior to a placebo and potentially comparable to standard treatments, although more research is needed to confirm the latter.[6][7] While THC might reduce nausea and vomiting in other contexts, this hasn’t been thoroughly researched.

THC may also reduce chronic pain to a small or moderate degree, with most research looking at neuropathic pain of various origins.[8][9] Limited research suggests that THC may also reduce pain due to cancer or multiple sclerosis.[10] Still, how THC compares to commonly used pain relievers is not particularly clear, and when used alongside opioid analgesics, THC doesn’t seem to reduce the required dose of opioids.[11][12]

What are THC’s main drawbacks?

THC is associated with a relatively high risk of side effects that tend to be dose-dependent (occurring more often with increasing doses).

The most common side effects of THC include sedation, dizziness, confusion, impaired cognition, impaired coordination, euphoria, anxiety, paranoia, heightened sensory awareness, headache, dry mouth, increased appetite, and nausea. THC can cause intoxication and impair the ability to drive.[1][13][14]

Less often, THC may cause vomiting, hallucinations, increased heart rate, orthostatic hypotension, and psychosis (in predisposed individuals).[1] There have also been case reports linking THC with an increased risk of seizure or heart attack.[15][16][17]

If THC is inhaled via smoking or vaping, it can increase the risk of lung disease or lung injury. Vaporizing THC can minimize the production of potentially cancer-causing compounds formed through combustion; however, there is still a risk of lung injury with vaping.[3]

How does THC work?

THC exerts its effects by interacting with the body’s endocannabinoid system, which involves binding to and activating the cannabinoid receptors cannabinoid receptor 1 (CB1) and cannabinoid receptor 2 (CB2).

The brain and spinal cord are rich in CB1 receptors, which are responsible for most of THC’s effects. When THC activates CB1 receptors, it alters neurotransmission (how neurons communicate) in a way that influences many bodily functions including pain signaling, appetite, cognition, the sleep-wake cycle, and nausea and vomiting. CB2 receptors are found predominantly in immune cells, and their activation by THC may have an anti-inflammatory effect.[9][18]

What are other names for THC?
Note that THC is also known as:
  • tetrahydrocannabinol
  • Delta-9-tetrahydrocannabinol
  • Δ9-Tetrahydrocannabinol
  • Nabilone (THC analog)
  • Dronabinol (THC analog)
Dosage information

Isolated THC can be taken orally as an extract in oil, capsule, or edible form. Alternatively, THC can be inhaled through smoking or vaporizing dried cannabis or cannabis concentrates. However, the types of THC available will vary depending on the legal status of THC in your region.

The recommended dosage of THC ranges from 2.5 mg to 30 mg daily. In general, it’s recommended to start low, go slow, and stay low to reduce the risk of side effects and minimize tolerance (a reduced response to the drug after repeated use).[1] This might look like starting at a dose of 2.5–5 mg and increasing slowly (every few days or as tolerated) until the desired therapeutic effect is achieved but side effects are kept to a minimum. If using a prescription medication containing a synthetic version of THC, the dosing may not necessarily be equivalent to natural THC.

THC taken orally will have a slower onset (1–3 hours) than inhaled THC, which has a rapid onset (5–10 minutes).[2]

You can estimate the dose of THC in dried cannabis based on the percent of THC in the product. Simply multiply the total dried weight in milligrams (1 gram = 1,000 milligrams) by the percentage of THC in the product. For example, if you have 0.25 g (250 mg) of dried cannabis with 10% THC, it will contain 25 mg of THC (250 mg x 0.10).

Don't miss out on the latest research

Update History
18 days ago

Full page update

major

We created brand new FAQs for the THC page! The update includes information about what THC is, how it works, and the potential benefits and risks of using THC.

References
  1. ^Campos DA, Mendivil EJ, Romano M, García M, Martínez MEA Systematic Review of Medical Cannabinoids Dosing in Human.Clin Ther.(2022-Dec)
  2. ^Chayasirisobhon SMechanisms of Action and Pharmacokinetics of Cannabis.Perm J.(2020-Dec)
  3. ^Poyatos L, Pérez-Acevedo AP, Papaseit E, Pérez-Mañá C, Martin S, Hladun O, Siles A, Torrens M, Busardo FP, Farré MOral Administration of Cannabis and Δ-9-tetrahydrocannabinol (THC) Preparations: A Systematic Review.Medicina (Kaunas).(2020 Jun 23)
  4. ^Vera Belgers, Jantine G Röttgering, Linda Douw, Martin Klein, Johannes C F Ket, Peter M van de Ven, Thomas Würdinger, Myra E van Linde, Johanna M Niers, Markus Weber, Marcel G Olde Rikkert, Jose Lopez-Sendon, Oscar Arrieta, Kristina B Svendsen, Marcos H N Chagas, Carlos M O de Almeida, Mathilde C M Kouwenhoven, Philip C de Witt HamerCannabinoids to Improve Health-Related Quality of Life in Patients with Neurological or Oncological Disease: A Meta-AnalysisCannabis Cannabinoid Res.(2022 Jul 21)
  5. ^Wang J, Wang Y, Tong M, Pan H, Li DMedical Cannabinoids for Cancer Cachexia: A Systematic Review and Meta-Analysis.Biomed Res Int.(2019)
  6. ^Chow R, Valdez C, Chow N, Zhang D, Im J, Sodhi E, Lock MOral cannabinoid for the prophylaxis of chemotherapy-induced nausea and vomiting-a systematic review and meta-analysis.Support Care Cancer.(2020 May)
  7. ^Chhabra M, Ben-Eltriki M, Paul A, Lê ML, Herbert A, Oberoi S, Bradford N, Bowers A, Rassekh SR, Kelly LECannabinoids for symptom management in children with cancer: A systematic review and meta-analysis.Cancer.(2023 Nov 15)
  8. ^Bilbao A, Spanagel RMedical cannabinoids: a pharmacology-based systematic review and meta-analysis for all relevant medical indications.BMC Med.(2022 Aug 19)
  9. ^Bradley Sainsbury, Jared Bloxham, Masoumeh Hassan Pour, Mariela Padilla, Reyes EncisoEfficacy of cannabis-based medications compared to placebo for the treatment of chronic neuropathic pain: a systematic review with meta-analysisJ Dent Anesth Pain Med.(2021 Dec)
  10. ^Zeng F, Wade A, Harbert K, Patel S, Holley JS, Dehghanpuor CK, Hopwood T, Marino S, Sophocleous A, Idris AIClassical cannabinoid receptors as target in cancer-induced bone pain: a systematic review, meta-analysis and bioinformatics validation.Sci Rep.(2024 Mar 9)
  11. ^Wang L, Hong PJ, May C, Rehman Y, Oparin Y, Hong CJ, Hong BY, AminiLari M, Gallo L, Kaushal A, Craigie S, Couban RJ, Kum E, Shanthanna H, Price I, Upadhye S, Ware MA, Campbell F, Buchbinder R, Agoritsas T, Busse JWMedical cannabis or cannabinoids for chronic non-cancer and cancer related pain: a systematic review and meta-analysis of randomised clinical trials.BMJ.(2021 Sep 8)
  12. ^Nielsen S, Picco L, Murnion B, Winters B, Matheson J, Graham M, Campbell G, Parvaresh L, Khor KE, Betz-Stablein B, Farrell M, Lintzeris N, Le Foll BOpioid-sparing effect of cannabinoids for analgesia: an updated systematic review and meta-analysis of preclinical and clinical studies.Neuropsychopharmacology.(2022-Jun)
  13. ^Whiting PF, Wolff RF, Deshpande S, Di Nisio M, Duffy S, Hernandez AV, Keurentjes JC, Lang S, Misso K, Ryder S, Schmidlkofer S, Westwood M, Kleijnen JCannabinoids for Medical Use: A Systematic Review and Meta-analysisJAMA.(2015 Jun 23-30)
  14. ^Rosager EV, Møller C, Sjögren MTreatment studies with cannabinoids in anorexia nervosa: a systematic review.Eat Weight Disord.(2021-Mar)
  15. ^Fogang YF, Camara M, Mbonda PC, Toffa D, Touré KLate onset epilepsy associated with marijuana abuse: a case report with MRI findings.Pan Afr Med J.(2014)
  16. ^Emoto J, Weeks K, Kallail KJAccidental Acute Cannabis Intoxication Presenting as Seizure in Pediatrics Patients.Kans J Med.(2020)
  17. ^Seffah KD, Kumar M, Naveen N, Pachchipulusu VK, Paudel Y, Patel A, Najam B, Desai HN, Illango J, Hamid PTo Weed or Not to Weed: A Systematic Review Exploring the Potential for Cannabis Use in Cardiovascular Disease, Mental Health and Pain Management.Cureus.(2023-Jun)
  18. ^Turcotte C, Blanchet MR, Laviolette M, Flamand NThe CB receptor and its role as a regulator of inflammation.Cell Mol Life Sci.(2016-Dec)
  19. ^Volkow ND, Han B, Compton WM, McCance-Katz EFSelf-reported Medical and Nonmedical Cannabis Use Among Pregnant Women in the United States.JAMA.(2019 Jul 9)
  20. ^Sorkhou M, Singla DR, Castle DJ, George TPBirth, cognitive and behavioral effects of intrauterine cannabis exposure in infants and children: A systematic review and meta-analysis.Addiction.(2024 Mar)
  21. ^Baía I, Domingues RMSMThe Effects of Cannabis Use during Pregnancy on Low Birth Weight and Preterm Birth: A Systematic Review and Meta-analysis.Am J Perinatol.(2024 Jan)
  22. ^Moss MJ, Bushlin I, Kazmierczak S, Koop D, Hendrickson RG, Zuckerman KE, Grigsby TMCannabis use and measurement of cannabinoids in plasma and breast milk of breastfeeding mothers.Pediatr Res.(2021 Oct)
  23. ^Chitmandeep Josan, Samantha Shiplo, Gerhard Fusch, Sandeep Raha, Alison K SheaCannabis use during lactation may alter the composition of human breast milkPediatr Res.(2023 Jun)
  24. ^"Cannabis". In Drugs and Lactation Database (LactMed®); USA: National Institute of Child Health and Human Development, updated 2023 Nov, cited 2024 Apr(2006)
  25. ^Petrilli K, Ofori S, Hines L, Taylor G, Adams S, Freeman TPAssociation of cannabis potency with mental ill health and addiction: a systematic review.Lancet Psychiatry.(2022 Sep)
  26. ^Arseneault L, Cannon M, Poulton R, Murray R, Caspi A, Moffitt TECannabis use in adolescence and risk for adult psychosis: longitudinal prospective study.BMJ.(2002 Nov 23)
  27. ^Fergusson DM, Horwood LJ, Ridder EMTests of causal linkages between cannabis use and psychotic symptoms.Addiction.(2005 Mar)
  28. ^Zammit S, Allebeck P, Andreasson S, Lundberg I, Lewis GSelf reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: historical cohort study.BMJ.(2002 Nov 23)
  29. ^van Os J, Bak M, Hanssen M, Bijl RV, de Graaf R, Verdoux HCannabis use and psychosis: a longitudinal population-based study.Am J Epidemiol.(2002 Aug 15)
  30. ^Kuepper R, van Os J, Lieb R, Wittchen HU, Höfler M, Henquet CContinued cannabis use and risk of incidence and persistence of psychotic symptoms: 10 year follow-up cohort study.BMJ.(2011-Mar-01)
  31. ^Caspi A, Moffitt TE, Cannon M, McClay J, Murray R, Harrington H, Taylor A, Arseneault L, Williams B, Braithwaite A, Poulton R, Craig IWModeration of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene X environment interaction.Biol Psychiatry.(2005-May-15)
  32. ^Bosnjak Kuharic D, Markovic D, Brkovic T, Jeric Kegalj M, Rubic Z, Vuica Vukasovic A, Jeroncic A, Puljak LCannabinoids for the treatment of dementia.Cochrane Database Syst Rev.(2021-Sep-17)
  33. ^Florindo Stella, Leandro C Lane Valiengo, Vanessa J R de Paula, Carlos Augusto de Mendonça Lima, Orestes V ForlenzaMedical cannabinoids for treatment of neuropsychiatric symptoms in dementia: a systematic reviewTrends Psychiatry Psychother.(2021 Oct-Dec)
  34. ^Zhornitsky S, Pelletier J, Assaf R, Giroux S, Li CR, Potvin SAcute effects of partial CB receptor agonists on cognition - A meta-analysis of human studies.Prog Neuropsychopharmacol Biol Psychiatry.(2021-Jan-10)
  35. ^Steardo L Jr, Carbone EA, Menculini G, Moretti P, Steardo L, Tortorella AEndocannabinoid System as Therapeutic Target of PTSD: A Systematic Review.Life (Basel).(2021 Mar 9)
  36. ^Lotfinia S, Afshar A, Yaseri A, Olff M, Quidé YFunctional brain changes after alternative pharmacological interventions in posttraumatic stress disorder: A systematic review of clinical trials.Brain Behav.(2023 Dec)
  37. ^Anastasia S Suraev, Nathaniel S Marshall, Ryan Vandrey, Danielle McCartney, Melissa J Benson, Iain S McGregor, Ronald R Grunstein, Camilla M HoyosCannabinoid therapies in the management of sleep disorders: A systematic review of preclinical and clinical studiesSleep Med Rev.(2020 May 16)
  38. ^Jane Metrik, Angela K Stevens, Rachel L Gunn, Brian Borsari, Kristina M JacksonCannabis use and posttraumatic stress disorder: prospective evidence from a longitudinal study of veteransPsychol Med.(2020 Jun 17)
  39. ^Zach Walsh, Robert Callaway, Lynne Belle-Isle, Rielle Capler, Robert Kay, Philippe Lucas, Susan HoltzmanCannabis for therapeutic purposes: patient characteristics, access, and reasons for useInt J Drug Policy.(2013 Nov)
  40. ^Velzeboer R, Malas A, Boerkoel P, Cullen K, Hawkins M, Roesler J, Lai WWCannabis dosing and administration for sleep: a systematic review.Sleep.(2022-Nov-09)
  41. ^Bhagavan C, Kung S, Doppen M, John M, Vakalalabure I, Oldfield K, Braithwaite I, Newton-Howes GCannabinoids in the Treatment of Insomnia Disorder: A Systematic Review and Meta-Analysis.CNS Drugs.(2020-Dec)
  42. ^Born JSlow-wave sleep and the consolidation of long-term memory.World J Biol Psychiatry.(2010-Jun)